# ASURE: Alzheimer Study Using oRal Edaravone

> **NCT05323812** · PHASE2 · COMPLETED · sponsor: **Treeway B.V.** · enrollment: 61 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** TW001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05323812
- **Lead sponsor:** Treeway B.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-01
- **Primary completion:** 2024-12-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2025-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05323812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05323812, "ASURE: Alzheimer Study Using oRal Edaravone". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05323812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*